Investing.com -- Hikma Pharmaceuticals PLC (LON:HIK) reported its third-quarter trading update on Thursday, confirming its full-year 2025 guidance but lowering its medium-term growth outlook, causing ...

Read More »

Hikma stock price target lowered to £28.50 by Deutsche Bank on mixed results

Investing.com - Deutsche Bank has lowered its price target on Hikma Pharmaceuticals Plc (LON: HIK) (OTC:HKMPF) to £28.50 from £31.00 while maintaining a Buy rating following the company’s mixed ...

Read More »

Investing in Hikma Pharmaceuticals (LON:HIK) five years ago would have delivered you a 38% gain

Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For ...

Read More »

London close: Stocks finish April in risk-on mood

Sharecast - Helping to buoy sentiment was the release of US data showing a large drop in price pressures, although other inflation readings Stateside appeared to point in the opposite direction. "The ...

Read More »

Hikma Pharmaceuticals PLC (LON:HIK) is largely controlled by institutional shareholders who own 50% of the company

To get a sense of who is truly in control of Hikma Pharmaceuticals PLC (LON:HIK), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of ...

Read More »